Martin Wermke Selected Research

Martin Wermke Research Topics

Disease

16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 06/2002
15	Neoplasms (Cancer) 01/2024 - 03/2010
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2010
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 09/2012
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2019
3	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2021
3	Melanoma (Melanoma, Malignant) 10/2023 - 03/2021
3	Iron Overload 05/2018 - 12/2012
2	Multiple Myeloma 01/2024 - 01/2023
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 11/2023 - 05/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
2	Cytokine Release Syndrome 11/2021 - 11/2021
2	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 01/2021
2	Adenocarcinoma 03/2021 - 01/2019
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 01/2019
2	Acute Promyelocytic Leukemia 01/2021 - 01/2010
2	Disease Progression 01/2019 - 02/2015
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2023
1	Dermatitis 10/2023
1	Diarrhea 10/2023
1	Exanthema (Rash) 10/2023
1	Nausea 10/2023
1	Neuroblastoma 10/2023
1	Adenocarcinoma of Lung 02/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Cytopenia 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Fatigue 01/2021
1	Asthenia 01/2021
1	Hepatitis 01/2019
1	Jaundice (Icterus) 01/2019
1	Colitis 01/2019
1	Cholestasis 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Adrenocortical Carcinoma 10/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 01/2024 - 01/2017
3	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 10/2011
3	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 12/2012
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 01/2023
2	CytokinesIBA 01/2024 - 01/2022
2	B-Cell Maturation AntigenIBA 01/2024 - 01/2023
2	Immune Checkpoint InhibitorsIBA 12/2022 - 02/2022
2	BI 836858IBA 11/2022 - 01/2022
2	PlatinumIBA 01/2022 - 01/2019
2	tocilizumab (atlizumab)FDA Link 11/2021 - 11/2021
2	tepotinibIBA 08/2021 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 01/2021
2	pembrolizumabIBA 01/2021 - 01/2019
2	RamucirumabIBA 01/2021 - 01/2019
2	IronIBA 05/2018 - 08/2014
2	Lenalidomide (CC 5013)FDA Link 10/2016 - 09/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2003 - 06/2002
1	mobocertinibIBA 04/2024
1	Tyrosine Kinase InhibitorsIBA 04/2024
1	sabatolimabIBA 11/2023
1	MucinsIBA 11/2023
1	Decitabine FDA Link 11/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2023
1	Lipase (Acid Lipase)FDA Link 10/2023
1	trametinibIBA 10/2023
1	Protein Kinases (Protein Kinase)IBA 10/2023
1	naporafenibIBA 10/2023
1	BI 6727IBA 05/2022
1	Phosphotransferases (Kinase)IBA 05/2022
1	H3B-8800IBA 12/2021
1	insulin receptor-related receptor (IRR)IBA 11/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021
1	axicabtagene ciloleucelIBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 04/2021
1	RNA (Ribonucleic Acid)IBA 04/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	TabletsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	EnzymesIBA 01/2021
1	capmatinibIBA 01/2021
1	selpercatinibIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2019
1	B7-H1 AntigenIBA 10/2018
1	avelumabIBA 10/2018
1	temsirolimus FDA Link 12/2016
1	TOR Serine-Threonine KinasesIBA 12/2016
1	SteroidsIBA 02/2016

Therapy/Procedure

13	Therapeutics 11/2023 - 06/2015
6	Cell Transplantation 01/2022 - 06/2011
6	Stem Cell Transplantation 09/2015 - 03/2010
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2021
2	Genomic Medicine 01/2024 - 11/2021
2	Immunotherapy 11/2023 - 11/2021
2	Transplantation 01/2020 - 05/2018
2	Hematopoietic Stem Cell Transplantation 01/2018 - 02/2016
1	Precision Medicine 01/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2022
1	Drug Tapering 11/2021